NCT01691339View on ClinicalTrials.gov

Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

February 28, 2013

Conditions
Influenza
Interventions
BIOLOGICAL

Influenza Virus Vaccine: Fluzone® 2012-2013 Formulation

0.5 mL, Intramuscular

BIOLOGICAL

Influenza Virus Vaccine: Fluzone® Intradermal 2012-2013 Formulation

0.1 mL, Intradermal

BIOLOGICAL

Influenza Virus Vaccine: Fluzone® 2012-2013 Formulation

0.5 mL, Intramuscular

BIOLOGICAL

Influenza Virus Vaccine: Fluzone® High-Dose 2012-2013 Formulation

0.5 mL, Intramuscular

Trial Locations (4)

33143

South Miami

33432

Boca Raton

51503

Council Bluffs

70006

Metairie

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01691339 - Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults. | Biotech Hunter | Biotech Hunter